Denis Patrick

Denis Patrick is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as a Board Member for EvolveImmune Therapeutics, Mission Therapeutics, eFFECTOR Therapeutics, and FoRx Therapeutics, while holding the position of Vice President at Pfizer since August 2010. At Pfizer, Denis Patrick leads Emerging Science & Innovation, serves as Managing Partner for Pfizer Ventures, and heads Partnering Innovation as well as external R&D strategies within the Oncology Research Unit. Previous experience includes key roles at GlaxoSmithKline as Director of Oncology Scientific Licensing and Director of Oncology Biology R&D, and at DuPont Pharmaceuticals as Associate Director, where Denis Patrick established significant lab and production facilities. A Research Fellow at Merck prior to these roles, Denis Patrick received a Ph.D. in Biochemistry from the University of Pennsylvania from 1990 to 1993.